Skip to main content
OpenTrials

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

387 public trials 106 recruiting studies
Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe

NCT00688623

Conditions
Adenocarcinoma, Advanced and Metastatic Silent Neuro-Endocrine Tumors, Carcinoid Tumor, +13 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Lyon, France
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Paris, France
View all 40 locations
View Trial Details
Completed

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

NCT01262235

Conditions
ACC, Adenocarcinoma, Adrenal Cortex Diseases, +26 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details
Completed

Non Interventional Post Marketing Programme in Neuroendocrine Tumours

NCT00747786

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • University Hospital of Wales Cardiff, United Kingdom
  • Aintree University Hospital Liverpool, United Kingdom
  • Royal Free Hospital London, United Kingdom
  • St. Bartholomew's Hospital London, United Kingdom
View Trial Details
Completed

Study to Evaluate the Use of Resources and the Costs Associated With Carcinoid Syndrome (CS) in Patients With NETs in Spain

NCT03220087

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Hospital General Univ. de Elche Alicante, Spain
  • ICO Badalona Badalona, Spain
  • Hospital Clínico y Provincial de Barcelona Barcelona, Spain
  • Hospital de Bellvitge Barcelona, Spain
View all 28 locations
View Trial Details
Completed

An Open-label, Multi-center, Expanded Access Study of Everolimus in Participants With Advanced Neuroendocrine Tumors (NETs) (Core Study) and an Extension Study to the Open-label, Multi-center, Expanded Access Study of Everolimus in Patients With Advanced NETs (E1)

NCT01595009

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Berlin, Germany
  • Novartis Investigative Site Chemnitz, Germany
  • Novartis Investigative Site Erlangen, Germany
View Trial Details
Completed

Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors

NCT02267967

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • the 307 Hospital of People's Liberation Army Beijing, Beijing Municipality, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details

Related conditions